Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, Abril A, Bachta A, Balint P, Barraclough K, Bianconi L, Buttgereit F, Carsons S, Ching D, Cid M, Cimmino M, Diamantopoulos A, Docken W, Duftner C, Fashanu B, Gilbert K, Hildreth P, Hollywood J, Jayne D, Lima M, Maharaj A, Mallen C, Martinez-Taboada V, Maz M, Merry S, Miller J, Mori S, Neill L, Nordborg E, Nott J, Padbury H, Pease C, Salvarani C, Schirmer M, Schmidt W, Spiera R, Tronnier D, Wagner A, Whitlock M, Matteson EL, Dasgupta B; European League Against Rheumatism; American College of Rheumatology.

Ann Rheum Dis. 2015 Oct;74(10):1799-807. doi: 10.1136/annrheumdis-2015-207492.

2.

2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, Abril A, Bachta A, Balint P, Barraclough K, Bianconi L, Buttgereit F, Carsons S, Ching D, Cid M, Cimmino M, Diamantopoulos A, Docken W, Duftner C, Fashanu B, Gilbert K, Hildreth P, Hollywood J, Jayne D, Lima M, Maharaj A, Mallen C, Martinez-Taboada V, Maz M, Merry S, Miller J, Mori S, Neill L, Nordborg E, Nott J, Padbury H, Pease C, Salvarani C, Schirmer M, Schmidt W, Spiera R, Tronnier D, Wagner A, Whitlock M, Matteson EL, Dasgupta B; European League Against Rheumatism; American College of Rheumatology.

Arthritis Rheumatol. 2015 Oct;67(10):2569-80. doi: 10.1002/art.39333.

3.

Patient-reported outcomes in polymyalgia rheumatica.

Matteson EL, Maradit-Kremers H, Cimmino MA, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Slott Jensen H, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Cantini F, Nannini C, Macchioni P, Pipitone N, Del Amo M, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazelman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Marcus R, Gonter NJ, Maz M, Crowson CS, Dasgupta B.

J Rheumatol. 2012 Apr;39(4):795-803. doi: 10.3899/jrheum.110977. Epub 2012 Mar 15.

4.

2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Jensen HS, Duhaut P, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Nannini C, Cantini F, Macchioni P, Pipitone N, Del Amo M, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazleman B, Silverman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Michet CJ, Marcus R, Gonter NJ, Maz M, Carter RE, Crowson CS, Matteson EL.

Arthritis Rheum. 2012 Apr;64(4):943-54. doi: 10.1002/art.34356.

5.

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Jensen HS, Duhaut P, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Nannini C, Cantini F, Macchioni P, Pipitone N, Amo MD, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazleman B, Silverman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Michet CJ, Marcus R, Gonter NJ, Maz M, Carter RE, Crowson CS, Matteson EL.

Ann Rheum Dis. 2012 Apr;71(4):484-92. doi: 10.1136/annrheumdis-2011-200329.

6.

Expression of the class I interferon-related MxA protein in temporal arteries in polymyalgia rheumatica and temporal arteritis.

Nordborg C, Larsson K, Aman P, Nordborg E.

Scand J Rheumatol. 2009 Mar-Apr;38(2):144-8. doi: 10.1080/03009740802448841.

PMID:
19177264
7.

An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis.

Schaufelberger C, Andersson R, Nordborg E, Hansson GK, Nordborg C, Wahlström J.

Inflammation. 2008 Dec;31(6):372-83. doi: 10.1007/s10753-008-9088-9.

PMID:
18975064
8.

Comparison of soluble ICAM-1, VCAM-1 and E-selectin levels in patients with episodic cluster headache and giant cell arteritis.

Remahl AI, Bratt J, Möllby H, Nordborg E, Waldenlind E.

Cephalalgia. 2008 Feb;28(2):157-63. doi: 10.1111/j.1468-2982.2007.01487.x.

PMID:
18197885
9.

Stereological study of neovascularization in temporal arteritis.

Nordborg C, Larsson K, Nordborg E.

J Rheumatol. 2006 Oct;33(10):2020-5. Epub 2006 Aug 15.

PMID:
16924688
10.

No additional steroid-sparing effect of cyclosporine A in giant cell arteritis.

Schaufelberger C, Möllby H, Uddhammar A, Bratt J, Nordborg E.

Scand J Rheumatol. 2006 Jul-Aug;35(4):327-9. No abstract available.

PMID:
16882602
11.

A Western blot and molecular genetic investigation of the estrogen receptor beta in giant cell arteritis.

Larsson K, Nordborg C, Moslemi AR, Nordborg E.

Clin Exp Rheumatol. 2006 Mar-Apr;24(2 Suppl 41):S17-9.

PMID:
16859590
12.

Difficulties in the development of histological scoring of the inflamed temporal arteries in giant cell arteritis.

Bharadwaj A, Dasgupta B, Wolfe K, Nordborg C, Nordborg E.

Rheumatology (Oxford). 2005 Dec;44(12):1579-80. Epub 2005 Nov 1. No abstract available.

PMID:
16263775
13.

Cell-type-specific expression of p53 and p21 in giant cell arteritis.

Nordborg C, Aman P, Persson M, Nordborg E.

APMIS. 2005 Sep;113(9):594-9.

PMID:
16218934
14.

Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis.

Larsson K, Mellström D, Nordborg E, Odén A, Nordborg E.

Ann Rheum Dis. 2006 Apr;65(4):529-32. Epub 2005 Aug 26. Erratum in: Ann Rheum Dis. 2006 Aug;65(8):1120. Nordborg, C [corrected to Nordborg, E].

15.
16.

Giant cell arteritis: strategies in diagnosis and treatment.

Nordborg E, Nordborg C.

Curr Opin Rheumatol. 2004 Jan;16(1):25-30. Review.

PMID:
14673385
17.

Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis.

D'Elia HF, Larsen A, Mattsson LA, Waltbrand E, Kvist G, Mellström D, Saxne T, Ohlsson C, Nordborg E, Carlsten H.

J Rheumatol. 2003 Jul;30(7):1456-63.

PMID:
12858441
18.

Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1.

D'Elia HF, Mattsson LA, Ohlsson C, Nordborg E, Carlsten H.

Arthritis Res Ther. 2003;5(4):R202-9. Epub 2003 May 1.

19.

Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis.

Forsblad D'Elia H, Larsen A, Waltbrand E, Kvist G, Mellström D, Saxne T, Ohlsson C, Nordborg E, Carlsten H.

Ann Rheum Dis. 2003 Jul;62(7):617-23.

20.

The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population.

Nordborg C, Johansson H, Petursdottir V, Nordborg E.

Rheumatology (Oxford). 2003 Apr;42(4):549-52.

PMID:
12649402
21.

Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment.

Nordborg E, Nordborg C.

Rheumatology (Oxford). 2003 Mar;42(3):413-21. Review.

PMID:
12626790
22.

Lower level of education in young adults with arthritis starting in the early adulthood.

Archenholtz B, Nordborg E, Bremell T.

Scand J Rheumatol. 2001;30(6):353-5.

PMID:
11846054
23.

Calcification of the internal elastic membrane in temporal arteries: its relation to age and gender.

Nordborg C, Nordborg E, Petursdottir V, Fyhr IM.

Clin Exp Rheumatol. 2001 Sep-Oct;19(5):565-8.

PMID:
11579717
24.

Estrogen receptor alpha in giant cell arteritis: a molecular genetic study.

Petursdottir V, Moslemi AR, Persson M, Nordborg E, Nordborg C.

Clin Exp Rheumatol. 2001 May-Jun;19(3):297-302.

PMID:
11407083
25.

Giant cell arteritis. Epidemiology, etiology and pathogenesis.

Nordborg C, Nordborg E, Petursdottir V.

APMIS. 2000 Nov;108(11):713-24. Review.

PMID:
11211963
26.

The pathogenesis of giant cell arteritis: morphological aspects.

Nordborg C, Nordborg E, Petursdottir V.

Clin Exp Rheumatol. 2000 Jul-Aug;18(4 Suppl 20):S18-21. Review.

PMID:
10948752
27.

Epidemiology of biopsy-positive giant cell arteritis: an overview.

Nordborg E.

Clin Exp Rheumatol. 2000 Jul-Aug;18(4 Suppl 20):S15-7. Review.

PMID:
10948751
28.

Estrogen receptors in giant cell arteritis. An immunocytochemical, western blot and RT-PCR study.

Petursdottir V, Nordborg E, Moraghebi N, Persson M, Nordborg C.

Clin Exp Rheumatol. 1999 Nov-Dec;17(6):671-7.

PMID:
10609065
29.

The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations.

Petursdottir V, Johansson H, Nordborg E, Nordborg C.

Rheumatology (Oxford). 1999 Dec;38(12):1208-12.

PMID:
10587547
30.

Search for varicella zoster virus in giant cell arteritis.

Nordborg C, Nordborg E, Petursdottir V, LaGuardia J, Mahalingam R, Wellish M, Gilden DH.

Ann Neurol. 1998 Sep;44(3):413-4.

PMID:
9749614
31.

No additive effect of cyclosporin A compared with glucocorticoid treatment alone in giant cell arteritis: results of an open, controlled, randomized study.

Schaufelberger C, Andersson R, Nordborg E.

Br J Rheumatol. 1998 Apr;37(4):464-5. No abstract available.

PMID:
9619904
32.

The effect of glucocorticoids on fat and lean tissue masses in giant cell arteritis.

Nordborg E, Schaufelberger C, Bosaeus I.

Scand J Rheumatol. 1998;27(2):106-11.

PMID:
9572635
33.

The role of CT in the diagnosis of sacro-iliitis.

Geijer M, Sihlbom H, Göthlin JH, Nordborg E.

Acta Radiol. 1998 May;39(3):265-8.

PMID:
9571940
34.

The inflammatory reaction in giant cell arteritis: an immunohistochemical investigation.

Nordborg E, Nordborg C.

Clin Exp Rheumatol. 1998 Mar-Apr;16(2):165-8.

PMID:
9536393
35.

The ineffectiveness of cyclical oral clodronate on bone mineral density in glucocorticoid-treated patients with giant-cell arteritis.

Nordborg E, Schaufelberger C, Andersson R, Bosaeus I, Bengtsson BA.

J Intern Med. 1997 Nov;242(5):367-71.

36.

Morphological aspects of giant cells in giant cell arteritis: an electron-microscopic and immunocytochemical study.

Nordborg E, Bengtsson BA, Petursdottir V, Nordborg C.

Clin Exp Rheumatol. 1997 Mar-Apr;15(2):129-34.

PMID:
9196863
37.

Atrophy of the aortic media in giant cell arteritis.

Petursdottir V, Nordborg E, Nordborg C.

APMIS. 1996 Mar;104(3):191-8.

PMID:
8611193
38.

Giant cell arteritis.

Nordborg E, Nordborg C, Malmvall BE, Andersson R, Bengtsson BA.

Rheum Dis Clin North Am. 1995 Nov;21(4):1013-26. Review.

PMID:
8592734
39.
40.

Giant cell arteritis. Epidemiology and treatment.

Nordborg E, Andersson R, Bengtsson BA.

Drugs Aging. 1994 Feb;4(2):135-44. Review.

PMID:
8186541
41.

Bone mineral content of the third lumbar vertebra during 18 months of prednisolone treatment for giant cell arteritis.

Nordborg E, Hansson T, Jonson R, Szücs J, Bengtsson BA.

Clin Rheumatol. 1993 Dec;12(4):455-60.

PMID:
8124904
42.

Plasma viscosity in giant cell arteritis as a predictor of disease activity.

Gudmundsson M, Nordborg E, Bengtsson BA, Bjelle A.

Ann Rheum Dis. 1993 Feb;52(2):104-9.

43.

Giant cell arteritis.

Nordborg E, Nordborg C, Bengtsson BA.

Curr Opin Rheumatol. 1992 Feb;4(1):23-30. Review.

PMID:
1543659
44.

Temporal artery morphology and morphometry in giant cell arteritis.

Nordborg E, Bengtsson BA, Nordborg C.

APMIS. 1991 Nov;99(11):1013-23.

PMID:
1958346
45.

[Polymyalgia rheumatica and temporal arteritis--different symptoms but the same disease].

Andersson R, Nordborg E, Bengtsson BA.

Lakartidningen. 1991 May 22;88(21):1957, 1959. Swedish. No abstract available.

PMID:
2056809
46.

von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis.

Nordborg E, Andersson R, Tengborn L, Edén S, Bengtsson BA.

Ann Rheum Dis. 1991 May;50(5):316-20.

47.

Epidemiology of biopsy-proven giant cell arteritis (GCA).

Nordborg E, Bengtsson BA.

J Intern Med. 1990 Apr;227(4):233-6.

PMID:
2324677
48.

Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy.

Nordborg E, Bengtsson BA.

BMJ. 1989 Aug 26;299(6698):549-50. No abstract available.

49.

HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis.

Andersson R, Hansson GK, Söderström T, Jonsson R, Bengtsson BA, Nordborg E.

Clin Exp Immunol. 1988 Jul;73(1):82-7.

Supplemental Content

Loading ...
Support Center